Recently, a new analysis of the women involved in the Women’s Health Initiative (WHI) was published in the October 20th issue of the Journal of the American Medical Association. In the new report, researchers have found that hormone replacement therapy not only increased the risk of breast cancer in women, but also the likelihood that she would die from the disease. While these findings may seem alarming at first, it’s important that you don’t let the media scare you into believing that all hormones are bad for you.

I know that my patients and their friends are an internet and media savvy group. As such, I am sure they are aware of the recently released JAMA (Journal of the American Medical Association) article that dealt with the incidence of breast cancer in patients undergoing long-term follow-up in the Women's Health Initiative (WHI) studies. This study was released several years ago after analyzing the results of giving hormone replacement therapy (HRT) in the form of synthetic Progestins (progesterone-like molecules) and Estrogens (Premarin) derived from horse urine which are most definitely NOT the same as human estrogen. Ultimately the study was discontinued because of the statistically increased incidence of cardiovascular disease and uterine cancer. The most recent data analysis looks at the incidence of breast cancer and it's complications in women from the original study who were followed for an additional 4 years. The results showed that there was a significantly increased incidence of breast cancer as well as the metastatic consequences of those cancers in the women who were given the synthetic hormones.

In a new analysis of the women involved in the Women's Health Initiative (WHI), researchers discovered that synthetic hormone replacement therapy used after menopause not only increased the risk of breast cancer in women, but also increased their risk of dying from the disease, when compared with women who did not receive treatment. These new findings were recently published in the October 20th issue of the Journal of the American Medical Association. The WHI was a federally funded study that analyzed more than16,500 postmenopausal women who were given either hormone replacement therapy or a placebo.

Recently, a new analysis of the women involved in the Women’s Health Initiative (WHI) was published in October 20th issue of the Journal of the American Medical Association (JAMA). In the new report, researchers have found that hormone replacement therapy not only increased the risk of breast cancer in women, but also the likelihood that she would die from the disease. While these findings may seem alarming at first, it’s important that you don’t let the media scare you into believing that all hormones are bad for you.

The media spotlight has honed in on hormone therapy once again, after the most recent findings from the Women’s Health Initiative (WHI) were published in last Wednesday’s issue of the Journal of the American Medical Association and once again women all over the world were done a huge disservice.

There’s a lot of talk in the media regarding the dangers of hormone therapy. Apparently new studies have shown that hormone therapy is more dangerous than doctors originally thought. I’ve been using bioidentical hormones for 9 months now and I’m concerned that I might be putting myself at risk for breast cancer and heart disease. My doctor tells me that bioidentical hormones are different than the hormones that were used in the WHI trials and that there dangerous side effects aren’t as common because bioidentical hormones are naturally occurring. In your opinion, what makes bioidentical hormones safer and/or more effective than other forms of HRT?

The expert physicians at BodyLogicMD are dedicated to removing the myths that surround hormones and hormone therapy, including such misconceptions as “Hormones cause cancer,” “All estrogens are the same,” “All progesterone’s are the same,” and “How you take hormones doesn’t matter.”  The focus on hormone replacement therapy and breast cancer is highlighted

Wyeth has a big presence in hormone replacement therapy, selling drugs women use to treat the symptoms of menopause. Sales of Wyeth's hormone replacement drugs, Premarin and Prempro, reached nearly $2 billion in 2001. The field took a big hit in 2002, when a large federal study found that women who took certain hormones had a higher risk of breast cancer, heart disease and stroke.

"The medical establishment must stop kowtowing to drug companies and start serving women's best interests -- and that involves widely prescribing bioidentical hormones. This will lead to healthier, happier women and, in the long run, help reduce America's skyrocketing health-care costs."

Dr. Jennifer Landa Explains Why She Offers Bioidentical Hormone Replacement Therapy

Many studies have linked hormone therapy to an increased risk of breast cancer. However, these studies show a link between breast cancer and artificial or synthetic hormones. Bioidentical hormones do not increase breast cancer risk.

The information provided on this blog is for reference use only, and does not constitute the rendering of legal, financial or other professional advice or recommendations by the BodyLogicMD affiliated physician. This page is not for the use of diagnosing and/or treating medical issues.